The story in detail
A tumour contains immune and supporting cells as well as cancer cells. Researchers combined millions of cellular and spatial measurements to identify nine recurring patterns in this environment. They then investigated whether related information could be recovered from cell-free DNA in blood. In nearly 100 melanoma patients, some patterns were strongly associated with immunotherapy response.
The approach aims to monitor complex tissue biology less invasively. It is not a system that reliably chooses the right drug for every patient. Sample size, cancer types and independent validation remain important limitations, and clinical decisions need prospective evaluation. The study does not show that blood analysis replaces biopsy. It introduces a candidate measurement strategy for research into more individualised treatment.
Study date: 2026-05-06 · Story: 20 October 2026
What was found?
Combining more than ten million cellular and spatial gene-expression profiles, researchers identified nine recurring tumour-neighbourhood patterns. Patterns recovered from blood cell-free DNA in nearly 100 melanoma patients were associated with immunotherapy response.
What does it mean?
The approach suggests blood samples may reveal how surrounding cells are organized, extending liquid-biopsy research beyond tumour cells alone.
Limitations
Detecting an association does not prove that using the test improves treatment decisions. Validation in additional patient groups and studies of clinical benefit are needed before routine use.
Sources and review scope
Original article (DOI) · Reviewed source 1
The original abstract and main results were reviewed.
Sources last checked: 20 October 2026.
Editorial expansion: 21.10.2026
Keep this story
Feedback to the editor
Only the editor can read this; it is not a public comment. Do not include personal health information.
Sign in to send feedback